Extendicare Stock Market Value
| EXETF Stock | USD 17.70 0.14 0.80% |
| Symbol | Extendicare |
Extendicare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Extendicare's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Extendicare.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Extendicare on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Extendicare or generate 0.0% return on investment in Extendicare over 90 days. Extendicare is related to or competes with Rhoen Klinikum, RHÖN-KLINIKUM Aktiengesellscha, WashTec AG, Life Healthcare, Panamera Holdings, Arjo AB, and Safilo Group. Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada More
Extendicare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Extendicare's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Extendicare upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.53 | |||
| Information Ratio | 0.268 | |||
| Maximum Drawdown | 16.03 | |||
| Value At Risk | (1.85) | |||
| Potential Upside | 3.04 |
Extendicare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Extendicare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Extendicare's standard deviation. In reality, there are many statistical measures that can use Extendicare historical prices to predict the future Extendicare's volatility.| Risk Adjusted Performance | 0.2578 | |||
| Jensen Alpha | 0.66 | |||
| Total Risk Alpha | 0.4287 | |||
| Sortino Ratio | 0.3771 | |||
| Treynor Ratio | 9.44 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Extendicare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Extendicare February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2578 | |||
| Market Risk Adjusted Performance | 9.45 | |||
| Mean Deviation | 1.36 | |||
| Semi Deviation | 0.7387 | |||
| Downside Deviation | 1.53 | |||
| Coefficient Of Variation | 318.87 | |||
| Standard Deviation | 2.16 | |||
| Variance | 4.65 | |||
| Information Ratio | 0.268 | |||
| Jensen Alpha | 0.66 | |||
| Total Risk Alpha | 0.4287 | |||
| Sortino Ratio | 0.3771 | |||
| Treynor Ratio | 9.44 | |||
| Maximum Drawdown | 16.03 | |||
| Value At Risk | (1.85) | |||
| Potential Upside | 3.04 | |||
| Downside Variance | 2.35 | |||
| Semi Variance | 0.5456 | |||
| Expected Short fall | (1.73) | |||
| Skewness | 2.52 | |||
| Kurtosis | 13.59 |
Extendicare Backtested Returns
Extendicare appears to be very steady, given 3 months investment horizon. Extendicare secures Sharpe Ratio (or Efficiency) of 0.32, which denotes the company had a 0.32 % return per unit of risk over the last 3 months. By reviewing Extendicare's technical indicators, you can evaluate if the expected return of 0.52% is justified by implied risk. Please utilize Extendicare's Coefficient Of Variation of 318.87, mean deviation of 1.36, and Downside Deviation of 1.53 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Extendicare holds a performance score of 25. The firm shows a Beta (market volatility) of 0.0706, which means not very significant fluctuations relative to the market. As returns on the market increase, Extendicare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Extendicare is expected to be smaller as well. Please check Extendicare's semi variance, and the relationship between the maximum drawdown and daily balance of power , to make a quick decision on whether Extendicare's price patterns will revert.
Auto-correlation | 0.83 |
Very good predictability
Extendicare has very good predictability. Overlapping area represents the amount of predictability between Extendicare time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Extendicare price movement. The serial correlation of 0.83 indicates that around 83.0% of current Extendicare price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.83 | |
| Spearman Rank Test | 0.83 | |
| Residual Average | 0.0 | |
| Price Variance | 0.61 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Extendicare Pink Sheet
Extendicare financial ratios help investors to determine whether Extendicare Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.